MENU
+Compare
ADCT
Stock ticker: NYSE
AS OF
Feb 21 closing price
Price
$1.63
Change
-$0.04 (-2.40%)
Capitalization
157.6M

ADCT ADC Therapeutics SA Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADCT with price predictions
Feb 18, 2025

ADCT in -7.95% downward trend, falling for three consecutive days on February 11, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ADCT declined for three days, in of 356 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for ADCT entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where ADCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on February 18, 2025. You may want to consider a long position or call options on ADCT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADCT just turned positive on February 13, 2025. Looking at past instances where ADCT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADCT advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

ADCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.604). P/E Ratio (0.000) is within average values for comparable stocks, (85.387). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.581). ADCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (2.106) is also within normal values, averaging (252.111).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 52.96% to -42 cents per share on March 13

ADC Therapeutics SA ADCT Stock Earnings Reports
Q4'24
Est.
$-0.43
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.17
Q4'23
Missed
by $0.51
The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -37 cents. With 320.75K shares outstanding, the current market capitalization sits at 157.60M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ADCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+5.00%
CLRB - ADCT
46%
Loosely correlated
+8.01%
ARVN - ADCT
42%
Loosely correlated
+1.86%
ANAB - ADCT
41%
Loosely correlated
-6.79%
AURA - ADCT
38%
Loosely correlated
-3.77%
PRME - ADCT
37%
Loosely correlated
+5.28%
More